KOP vs RARE · P/E 28, rev $975.4M vs rev $350.0M
Koppers Holdings Inc (KOP) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Koppers Holdings Inc (KOP) is a specialty chemicals company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported KOP revenue for 2026-06-30 was $975.4M. Net income was -$140.4M. KOP currently screens at market cap $695.4M and trailing P/E 28.3.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
KOP currently screens at market cap $695.4M and trailing P/E 28.3. RARE currently screens at market cap $2.79B.
Not investment advice. Open the KOP and RARE stock pages for the full models.
Not investment advice.